⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL194506 | 1.00 | — | — | |
| Charcoal, Activated SCHEMBL31423781 | 0.95 | — | — | |
| Trimethylammonium SCHEMBL27522747 | 0.87 | — | — | |
| SCHEMBL27695844 | 0.83 | — | — | |
| Methyl Alcohol SCHEMBL27801280 | 0.80 | — | — | |
| SCHEMBL28941779 | 0.78 | LMNA (0.31) | — | |
| SCHEMBL28958957 | 0.74 | — | — | |
| SCHEMBL1862942 | 0.74 | — | — | |
| SCHEMBL9527000 | 0.70 | — | — | |
| SCHEMBL28428063 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0966456-B1 | TAXOID REVERSAL AGENTS FOR DRUG-RESISTANCE IN CANCER CHEMOTHERAPY AND PHARMACEUTICAL COMPOSITIONS THEREOF | UNIV NEW YORK STATE RES FOUND (US) | 2003-04-02 | — | — | EP | claimed |
| US-5811452-A | ADMINISTERING WITH PACLITAXEL OR DOXORUBICIN | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1998-09-22 | — | — | US | claimed |
| US-11203583-B2 | Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2021-12-21 | — | — | US | disclosed |
| US-20200247775-A1 | PRODRUG AND PROFLUORESCENT COMPOUNDS FOR SELECTIVE MITOCHONDRIAL IMAGING AND THERAPEUTIC TARGETING | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2020-08-06 | — | — | US | disclosed |
| US-10604501-B2 | Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2020-03-31 | — | — | US | disclosed |
| US-20190330176-A1 | PRODRUG AND PROFLUORESCENT COMPOUNDS FOR SELECTIVE MITOCHONDRIAL IMAGING AND THERAPEUTIC TARGETING | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2019-10-31 | — | — | US | disclosed |
| US-20110212986-A1 | ANTI-FLAVIVIRUS THERAPEUTIC | HEALTH RESEARCH, INC. (US) | 2011-09-01 | — | — | US | disclosed |
| WO-2010022238-A2 | ANTI-FLAVIVIRUS THERAPEUTIC | HEALTH RESEARCH, INC. (US) | 2010-02-25 | — | — | WO | disclosed |
| EP-1497276-B1 | CONVERSION OF TAXANE MOLECULES | NATURAL PHARMACEUTICALS INC (US) | 2008-08-20 | — | — | EP | disclosed |
| US-7220872-B2 | Conversion of taxane molecules | NATURAL PHARMACEUTICALS, INC. (US) | 2007-05-22 | — | — | US | disclosed |
| US-7176325-B2 | Selective acylation of secondary hydroxyl groups | NATURAL PHARMACEUTICALS, INC. (US) | 2007-02-13 | — | — | US | disclosed |
| US-20050234249-A1 | Conversion of taxane molecules | PHYTON HOLDINGS, LLC | 2005-10-20 | — | — | US | disclosed |
| US-20050176975-A1 | Selective acylation of secondary hydroxyl groups | PHYTON HOLDINGS, LLC | 2005-08-11 | — | — | US | disclosed |
| CN-1450997-A | Inhibitors of copper-containing amine oxidases | BIOTIE THERAPIES CORP (FI) | 2003-10-22 | — | — | CN | disclosed |
| EP-0966456-B1 | TAXOID REVERSAL AGENTS FOR DRUG-RESISTANCE IN CANCER CHEMOTHERAPY AND PHARMACEUTICAL COMPOSITIONS THEREOF | UNIV NEW YORK STATE RES FOUND (US) | 2003-04-02 | — | — | EP | disclosed |
| EP-1230225-A2 | PHARMACEUTICALLY ACTIVE 4-SUBSTITUTED PYRIMIDINE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001032632-A2 | PHARMACEUTICALLY ACTIVE 4-SUBSTITUTED PYRIMIDINE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2001-05-10 | — | — | WO | disclosed |
| US-5811452-A | ADMINISTERING WITH PACLITAXEL OR DOXORUBICIN | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1998-09-22 | — | — | US | disclosed |